Lanrektan® contains the active substance tadalafil and belongs to a group of medicines called phosphodiesterase-5 inhibitors (PDE-5 inhibitors).
Lanrektan® 5 mg, 10 mg and 20 mg is used to treat adult men with erectile dysfunction. This is when a man cannot get or maintain a hard, erect penis for sexual activity. Tadalafil showed a significant improvement in terms of getting a hard, erect penis for sexual activity.
It is important to note that Lanrektan® does not work without sexual stimulation. Partnered foreplay may be necessary, just as if you had not taken a medicine for erectile dysfunction.
Lanrektan® 5 mg is also used to treat adult men with urinary problems associated with a common condition called benign prostatic hyperplasia. This is where the prostate gland gets bigger with age. Signs include difficulty urinating, a feeling of not having a completely empty bladder and a more frequent need to go to the toilet even at night. Lanrektan® improves blood flow and relaxes the muscles of the prostate and bladder, which can reduce the discomfort of benign prostate enlargement. These symptoms have been shown to improve as early as 1 to 2 weeks after starting treatment with tadalafil.
| Strength | Pack size |
| 5 mg | 10, 30, 90 |
| 10 mg | 4, 12, 40 |
| 20 mg | 4, 12, 40 |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information